Diffusion imaging for evaluation of tumor therapies in preclinical animal models

The increasing development of novel targeted therapies for treating solid tumors has necessitated the development of technology to determine their efficacy in preclinical animal models. One such technology that can non-invasively quantify early changes in tumor cellularity as a result of an efficacious therapy is diffusion MRI. In this overview we present some theories as to the origin of diffusion changes as a result of tumor therapy, a robust methodology for acquisition of apparent diffusion coefficient maps and some applications of determining therapeutic efficacy in a variety therapeutic regimens and animal models.

[1]  T. Chenevert,et al.  Evaluation of (E)‐2′‐deoxy‐2′‐(fluoromethylene)cytidine on the 9L rat brain tumor model using MRI , 2003, NMR in biomedicine.

[2]  Bradford A Moffat,et al.  Evaluation of cancer therapy using diffusion magnetic resonance imaging. , 2003, Molecular cancer therapeutics.

[3]  Bradford A Moffat,et al.  The use of 19F spectroscopy and diffusion-weighted MRI to evaluate differences in gene-dependent enzyme prodrug therapies. , 2004, Molecular therapy : the journal of the American Society of Gene Therapy.

[4]  Thomas L. Chenevert,et al.  Molecular Imaging of Gene Expression and Efficacy following Adenoviral-Mediated Brain Tumor Gene Therapy , 2002 .

[5]  J G Pipe,et al.  A progressive gradient moment nulling design technique , 1991, Magnetic resonance in medicine.

[6]  G. Curt.  The use of animal models in cancer drug discovery and development , 1994, Stem cells.

[7]  T. Chenevert,et al.  Magnetic resonance imaging in cancer research. , 2002, European journal of cancer.

[8]  P. V. van Zijl,et al.  Diffusion Weighting by the Trace of the Diffusion Tensor within a Single Scan , 1995, Magnetic resonance in medicine.

[9]  M. Christian,et al.  Measuring response in solid tumors: unidimensional versus bidimensional measurement. , 1999, Journal of the National Cancer Institute.

[10]  P. Grenier,et al.  MR imaging of intravoxel incoherent motions: application to diffusion and perfusion in neurologic disorders. , 1986, Radiology.

[11]  Risto A Kauppinen,et al.  Monitoring cytotoxic tumour treatment response by diffusion magnetic resonance imaging and proton spectroscopy , 2002, NMR in biomedicine.

[12]  R. Kauppinen,et al.  Quantitative 1H nuclear magnetic resonance diffusion spectroscopy of BT4C rat glioma during thymidine kinase-mediated gene therapy in vivo: identification of apoptotic response. , 1998, Cancer research.

[13]  J G Pipe,et al.  In vivo MR determination of water diffusion coefficients and diffusion anisotropy: correlation with structural alteration in gliomas of the cerebral hemispheres. , 1995, AJNR. American journal of neuroradiology.

[14]  Thomas L Chenevert,et al.  Magnetic Resonance Imaging and Spectroscopy: Application to Experimental Neuro-Oncology. , 1994, Quarterly of magnetic resonance in biology and medicine.

[15]  T. Chenevert,et al.  Growth kinetics and treatment response of the intracerebral rat 9L brain tumor model: a quantitative in vivo study using magnetic resonance imaging. , 1995, Clinical cancer research : an official journal of the American Association for Cancer Research.

[16]  T. Cascino,et al.  Response criteria for phase II studies of supratentorial malignant glioma. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  C. Wilson,et al.  Animal models of brain tumors. , 1977, National Cancer Institute monograph.

[18]  J. E. Tanner,et al.  Spin diffusion measurements : spin echoes in the presence of a time-dependent field gradient , 1965 .

[19]  Bradford A. Moffat,et al.  Diffusion MRI: A New Strategy for Assessment of Cancer Therapeutic Efficacy , 2002, Molecular imaging.

[20]  Bradford A Moffat,et al.  Therapeutic Efficacy of DTI-015 using Diffusion Magnetic Resonance Imaging as an Early Surrogate Marker , 2004, Clinical Cancer Research.

[21]  Stephan E Maier,et al.  Early detection of response to radiation therapy in patients with brain malignancies using conventional and high b-value diffusion-weighted magnetic resonance imaging. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[22]  C. Wilson,et al.  Development of an animal brain tumor model and its response to therapy with 1,3-bis(2-chloroethyl)-1-nitrosourea. , 1973, Cancer research.

[23]  C. Wilson,et al.  In vivo clonogenic tumor cell kinetics following 1,3-bis(2-chloroethyl)-1-nitrosourea brain tumor therapy. , 1976, Cancer research.

[24]  T L Chenevert,et al.  Monitoring early response of experimental brain tumors to therapy using diffusion magnetic resonance imaging. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

[25]  R. Gillies,et al.  Early increases in breast tumor xenograft water mobility in response to paclitaxel therapy detected by non-invasive diffusion magnetic resonance imaging. , 1999, Neoplasia.

[26]  J C Gore,et al.  Analysis and correction of motion artifacts in diffusion weighted imaging , 1994, Magnetic resonance in medicine.

[27]  P. Sheridan,et al.  Animal models for brain tumors: historical perspectives and future directions. , 1994, Journal of neurosurgery.

[28]  A. Rehemtulla,et al.  Diffusion MRI detects early events in the response of a glioma model to the yeast cytosine deaminase gene therapy strategy , 2000, Gene Therapy.

[29]  S E Maier,et al.  Monitoring response to convection-enhanced taxol delivery in brain tumor patients using diffusion-weighted magnetic resonance imaging. , 2001, Cancer research.

[30]  J. M. Taylor,et al.  Diffusion magnetic resonance imaging: an early surrogate marker of therapeutic efficacy in brain tumors. , 2000, Journal of the National Cancer Institute.

[31]  A. Song,et al.  Optimized isotropic diffusion weighting , 1995, Magnetic resonance in medicine.

[32]  J. Pipe,et al.  Early detection of treatment response by diffusion-weighted 1H-NMR spectroscopy in a murine tumour in vivo. , 1996, British Journal of Cancer.